Closed · PA-18-851 · CFDA 93.286 · Discretionary
NIBIB Supplements to NCATS CTSA Programs to Support NIBIB Translational Research Scholars (Admin Supp Clinical Trials Optional)
Federal grant opportunity posted by National Institutes of Health, cataloged on Grants.gov.
- Varies
- Award range
- Closed
- Status
- November 5, 2018
- Close date
- -
- Expected awards
The verdict
NIBIB Supplements to NCATS CTSA Programs to Support NIBIB Translational Research Scholars (Admin Supp Clinical Trials Optional) is a closed discretionary listing from National Institutes of Health that offered Varies by applicant. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 12,419 other opportunities from National Institutes of Health.
- Varies
- award range
- Closed
- application status
- 93.286
- CFDA program
- 12,419
- other opportunities from National Institutes of Health
Archived opportunity record
NIBIB Supplements to NCATS CTSA Programs to S… is closed (last close November 5, 2018). The parent program page for CFDA 93.286 is the reliable place to catch re-announcements. National Institutes of Health still indexes 12,419 other opportunities here.
According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.
Deadline tracker
Application window closed
Closed November 5, 2018
Instrument
Grant
Description
The purpose of this administrative supplement is to facilitate translational research partnerships between junior researchers with quantitative backgrounds (in engineering or computational or physical sciences) and junior clinician-scientists from active CTSA institutions (PAR-15-304, PAR-18-464). The supplement will support the quantitative researcher, the NIBIB Translational Research Scholar, contingent upon his/her collaborating with a clinician-scientist KL2 scholar, the "partnering clinician-scientist". The partnering clinician-scientist will be supported independently of this supplement through the parent KL2 award throughout the duration of the proposed supplement. Both team members will be selected by the KL2 PI. The KL2 PI will assist the NIBIB Translational Research Scholar and the partnering clinician-scientist in developing a translational research project aligned with NIBIBs research mission under the guidance of their identified basic and clinical/translational science mentors. Based on this project, the KL2 PI will submit a supplement request under this FOA.
Multi-door applicant board · 3 Grants.gov types
Grants.gov prints 3 distinct applicant types for NIBIB Supplements to NCATS CTSA Programs to S… (Public / state-controlled institutions of higher education; Private institutions of higher education; Others (see official listing text)). Filter fit against the official announcement before drafting. The extract does not mark applicant cost-sharing as required. Instrument: Grant. Funding-activity code maps to Health (HL). Only 256 other National Institutes of Health listings share this exact eligibility-code string (2% of 12,420).
- Code 06
- Public / state-controlled institutions of higher education
- Code 20
- Private institutions of higher education
- Code 25
- Others (see official listing text)
Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Parent Grant Program
Discovery Research for Cancer Diagnostics
National Institutes of Health
Agency Contact
NIH OER Webmaster FBOWebmaster@OD.NIH.GOV
More from National Institutes of Health
Validation Center for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U54 Clinical Trials Not Allowed)
Logistics Center for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U24 Clinical Trials Not Allowed)
Development and Testing of a Multi-use Frameworks Playbook for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U01 Clinical Trial Not Allowed)
PRIMED-AI: Data-to-Model Academic-Industrial Partnerships (D2M-AIP) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (UG3/UH3 Clinical Trial Optional)
Model-to-Clinic (M2C) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (UG3/UH3, Clinical Trial Optional)
What to do next
NIBIB Supplements to NCATS CTSA Programs to S… is closed; use the parent program and agency catalog for the next funding cycle.
- Parent CFDA 93.286 may publish future NOFOs under the same assistance listing. Open program
- Discovery Research for Cancer Diagnostics indexes 78 Grants.gov listings in this extract. Program profile
- National Institutes of Health lists 12,419 other indexed opportunities on PlainGrants. Agency catalog
Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |